GYRE

$0.00

(

0.00%

)
Quote details

stock

Gyre Therapeutics Inc.

NASDAQ | GYRE

7.76

USD

$0.00

(

0.00%

)

At Close (As of Dec 12, 2025)

$758.14M

Market Cap

196.75

P/E Ratio

0.04

EPS

$14.42

52 Week High

$6.11

52 Week Low

HEALTHCARE

Sector

GYRE Chart

Recent Chart
Price Action

GYRE Technicals

Tags:

GYRE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $102M
Total Revenue $106M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income $16M
Selling General And Administrative $16M
Research And Development $12M
Operating Expenses $86M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $1.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax $23M
Income Tax Expense $5.3M
Interest And Debt Expense -
Net Income From Continuing Operations $18M
Comprehensive Income Net Of Tax -
Ebit $16M
Ebitda $18M
Net Income $12M

Revenue & Profitability

Earnings Performance

GYRE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $125M
Total Current Assets $65M
Cash And Cash Equivalents At Carrying Value $12M
Cash And Short Term Investments $12M
Inventory $6.3M
Current Net Receivables $29M
Total Non Current Assets $61M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.7M
Intangible Assets Excluding Goodwill $1.7M
Goodwill -
Investments -
Long Term Investments $25M
Short Term Investments $15M
Other Current Assets $2.6M
Other Non Current Assets -
Total Liabilities $27M
Total Current Liabilities $20M
Current Accounts Payable $108K
Deferred Revenue -
Current Debt -
Short Term Debt $713K
Total Non Current Liabilities $7.5M
Capital Lease Obligations $1.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.6M
Other Current Liabilities $16M
Other Non Current Liabilities $7K
Total Shareholder Equity $63M
Treasury Stock -
Retained Earnings -$73M
Common Stock $86K
Common Stock Shares Outstanding $102M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$3.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $3.1M
Change In Receivables -
Change In Inventory -$2.1M
Profit Loss -
Cashflow From Investment -$20M
Cashflow From Financing $2.1M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $18M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $102M
Total Revenue $106M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income $16M
Selling General And Administrative $16M
Research And Development $12M
Operating Expenses $86M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $1.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax $23M
Income Tax Expense $5.3M
Interest And Debt Expense -
Net Income From Continuing Operations $18M
Comprehensive Income Net Of Tax -
Ebit $16M
Ebitda $18M
Net Income $12M

Dividends

Field Value
Ex Dividend Date 2023-01-13
Declaration Date 2022-12-27
Record Date 2023-01-05
Payment Date 2023-01-12
Amount 0.24

GYRE News

GYRE Profile

Gyre Therapeutics Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

None

LPTX
+368.57%
$2.05
PAVS
+22.02%
$0.04
YGMZ
-61.42%
$0.02
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
F
+1.64%
$13.63
WOK
-22.44%
$0.13
ATPC
-20.66%
$0.14
KAVL
-15.50%
$0.16
ADAP
-15.14%
$0.05
RIVN
+15.94%
$19.05
CGC
+23.00%
$1.39
AKAN
+21.32%
$0.95
SOND
-23.45%
$0.12
ZDGE
+60.49%
$3.90
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
NVDA
-0.35%
$180.28
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
TSLA
+0.43%
$448.81
CDE
+9.45%
$17.48
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
OCG
+50.38%
$1.37
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
VIVK
+9.45%
$0.08
AVGO
-9.61%
$367.30
FRMI
-39.81%
$9.17
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
TE
-11.09%
$5.21
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
APLT
-46.24%
$0.11
SOUN
-1.47%
$12.03
CNQ
-1.72%
$33.14
EXK
+4.20%
$9.41
CAN
-1.75%
$0.92
EOSE
+11.15%
$16.44
TWOH
0.00%
$0.00
INTC
-0.51%
$39.30
DRCT
-11.02%
$0.07
MSTR
-0.72%
$183.30
GRYP
-10.38%
$1.38
PSKY
-4.07%
$14.12
ASST
+0.48%
$0.92
MU
-1.99%
$258.46
MODV
-25.22%
$0.43
CX
+2.94%
$11.19
ITUB
+2.39%
$7.27
PLUG
0.00%
$2.35
ROIV
+5.43%
$21.34
NVVE
-35.89%
$0.10
RZLT
+14.28%
$1.60
MDLZ
-0.18%
$53.79
ONDS
-0.83%
$8.94
NVTS
+0.65%
$9.18
TSM
-1.44%
$304.85
BMNR
-4.27%
$36.74
CPNG
-0.76%
$25.86
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
OWL
-2.71%
$16.11
RXRX
-3.98%
$4.58
QUBT
+2.14%
$12.83
VALE
-4.74%
$12.65
IVP
-5.46%
$0.05
CLSK
-0.50%
$14.74
ET
-0.24%
$16.41
GGB
+2.24%
$3.65
ORCL
-3.57%
$191.74
NBIS
+0.73%
$94.28
PG
+0.67%
$140.76
NEM
+5.31%
$99.42
AVTR
-0.34%
$11.47
SPR
+0.22%
$39.50
CVS
+2.35%
$80.83
FSM
+2.51%
$9.78
KMI
+0.86%
$26.82
U
+0.51%
$49.23
C
+0.58%
$111.74
HOOD
-0.81%
$122.37
RR
-7.47%
$4.33
PLTR
-3.53%
$180.90
PPBT
-0.44%
$0.82
CVE
-0.78%
$17.72
UEC
+9.52%
$14.15
HPQ
+0.86%
$25.41
CHWY
-3.39%
$34.17
SONN
-59.35%
$1.26
EQT
-2.06%
$56.07
LPTX
+368.57%
$2.05
PAVS
+22.02%
$0.04
YGMZ
-61.42%
$0.02
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
F
+1.64%
$13.63
WOK
-22.44%
$0.13
ATPC
-20.66%
$0.14
KAVL
-15.50%
$0.16
ADAP
-15.14%
$0.05
RIVN
+15.94%
$19.05
CGC
+23.00%
$1.39
AKAN
+21.32%
$0.95
SOND
-23.45%
$0.12
ZDGE
+60.49%
$3.90
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
NVDA
-0.35%
$180.28
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
TSLA
+0.43%
$448.81
CDE
+9.45%
$17.48
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
OCG
+50.38%
$1.37
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
VIVK
+9.45%
$0.08
AVGO
-9.61%
$367.30
FRMI
-39.81%
$9.17
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
TE
-11.09%
$5.21
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
APLT
-46.24%
$0.11
SOUN
-1.47%
$12.03
CNQ
-1.72%
$33.14
EXK
+4.20%
$9.41
CAN
-1.75%
$0.92
EOSE
+11.15%
$16.44
TWOH
0.00%
$0.00
INTC
-0.51%
$39.30
DRCT
-11.02%
$0.07
MSTR
-0.72%
$183.30
GRYP
-10.38%
$1.38
PSKY
-4.07%
$14.12
ASST
+0.48%
$0.92
MU
-1.99%
$258.46
MODV
-25.22%
$0.43
CX
+2.94%
$11.19
ITUB
+2.39%
$7.27
PLUG
0.00%
$2.35
ROIV
+5.43%
$21.34
NVVE
-35.89%
$0.10
RZLT
+14.28%
$1.60
MDLZ
-0.18%
$53.79
ONDS
-0.83%
$8.94
NVTS
+0.65%
$9.18
TSM
-1.44%
$304.85
BMNR
-4.27%
$36.74
CPNG
-0.76%
$25.86
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
OWL
-2.71%
$16.11
RXRX
-3.98%
$4.58
QUBT
+2.14%
$12.83
VALE
-4.74%
$12.65
IVP
-5.46%
$0.05
CLSK
-0.50%
$14.74
ET
-0.24%
$16.41
GGB
+2.24%
$3.65
ORCL
-3.57%
$191.74
NBIS
+0.73%
$94.28
PG
+0.67%
$140.76
NEM
+5.31%
$99.42
AVTR
-0.34%
$11.47
SPR
+0.22%
$39.50
CVS
+2.35%
$80.83
FSM
+2.51%
$9.78
KMI
+0.86%
$26.82
U
+0.51%
$49.23
C
+0.58%
$111.74
HOOD
-0.81%
$122.37
RR
-7.47%
$4.33
PLTR
-3.53%
$180.90
PPBT
-0.44%
$0.82
CVE
-0.78%
$17.72
UEC
+9.52%
$14.15
HPQ
+0.86%
$25.41
CHWY
-3.39%
$34.17
SONN
-59.35%
$1.26
EQT
-2.06%
$56.07

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.